Curcumin β‐D‐glucuronide exhibits anti–tumor effects on oxaliplatin‐resistant colon cancer with less toxicity in vivo
Hitomi Ozawa‐Umeta, Masashi Kanai(Kyoto University Hospital)
Cited by 29
Related Papers
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
|Cancer Chemotherapy and Pharmacology|2013|191